
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Highly active antiretroviral therapy dosed just once a day is more effective in reducing HIV viral levels than twice-daily therapy, researchers reported at the Third International AIDS Society Conference on HIV Pathogenesis and Treatment. A study of U.S. patient records from 218 HIV-positive adults showed that 68% of those on once-daily regimens achieved HIV viral loads below 50, compared to 45% of those on twice-daily therapy. Only 19% of those on once-daily regimens experienced viral rebounds, compared with 49% of those on twice-daily therapy. The better virologic control was likely linked to better adherence to the simpler regimen, the researchers say, noting that 83% of patients taking once-daily therapy reported adherence of 95% or better, compared to 63% of those taking anti-HIV medications twice a day.
From our Sponsors
Most Popular
Plus: Featured Video